Recent discussions on X about Cerence Inc. (CRNC) have centered around a series of insider sales by top executives, sparking curiosity and concern among investors. Posts on the platform highlight that multiple high-ranking officials, including the CEO and other key officers, sold significant shares in early October 2025, with transactions amounting to millions of dollars. This flurry of activity has led to speculation about the company’s future direction, especially amidst its impressive stock surge of over 230% in the past year.
While some users on X express unease over the timing of these sales, others note that such moves are sometimes tied to tax obligations or personal financial planning rather than a lack of confidence in the company. There’s also chatter about Cerence’s strong position in AI-driven automotive technology, with a few pointing to the potential for further growth as a counterbalance to the insider activity. The conversation remains dynamic, with many watching for the company’s next moves to gauge the true impact of these developments.
Note: This discussion summary was generated from an AI condensation of post data.
Cerence Inc. Insider Trading Activity
Cerence Inc. insiders have traded $CRNC stock on the open market 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CRNC stock by insiders over the last 6 months:
- JENNIFER SALINAS (EVP Chief Admin Officer) has made 0 purchases and 2 sales selling 142,778 shares for an estimated $1,786,746.
- BRIAN M KRZANICH (Chief Executive Officer) sold 132,075 shares for an estimated $1,513,381
- ANTONIO RODRIQUEZ (CFO) sold 38,347 shares for an estimated $489,204
- CHRISTIAN MENTZ (EVP, Chief Revenue Officer) has made 0 purchases and 2 sales selling 30,872 shares for an estimated $393,757.
- NILS SCHANZ (EVP Product & Technology) sold 30,560 shares for an estimated $389,863
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Cerence Inc. Hedge Fund Activity
We have seen 85 institutional investors add shares of Cerence Inc. stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- D. E. SHAW & CO., INC. removed 705,929 shares (-59.8%) from their portfolio in Q2 2025, for an estimated $7,207,535
- JANE STREET GROUP, LLC removed 673,899 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $6,880,508
- MILLENNIUM MANAGEMENT LLC removed 569,913 shares (-40.8%) from their portfolio in Q2 2025, for an estimated $5,818,811
- MORGAN STANLEY removed 363,940 shares (-35.3%) from their portfolio in Q2 2025, for an estimated $3,715,827
- UBS GROUP AG removed 333,009 shares (-78.8%) from their portfolio in Q2 2025, for an estimated $3,400,021
- MARSHALL WACE, LLP added 267,832 shares (+31.7%) to their portfolio in Q2 2025, for an estimated $2,734,564
- ACADIAN ASSET MANAGEMENT LLC removed 255,727 shares (-24.4%) from their portfolio in Q2 2025, for an estimated $2,610,972
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Cerence Inc. Price Targets
Multiple analysts have issued price targets for $CRNC recently. We have seen 2 analysts offer price targets for $CRNC in the last 6 months, with a median target of $10.0.
Here are some recent targets:
- Mark Delaney from Goldman Sachs set a target price of $10.0 on 08/07/2025
- Colin Langan from Wells Fargo set a target price of $10.0 on 05/08/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
